Results 101 to 110 of about 338,477 (271)
Radiogenic risk of colorectal cancer in the Southern Urals Population Exposed to Radiation Cohort
Colorectal cancer (colon, rectum, rectosigmoid and anus) is one of the most frequently registered cancer sites. Apart from main risk factors for the development of cancer of this localization (dietary disorders, obesity, alcohol and tobacco use, contact ...
S. S. Silkin, L. D. Mikryukova
doaj +1 more source
This study identified six clinically relevant quality indicators feasible to measure using NSW population‐based data. However, these indicators were restricted to surgical processes and outcomes. A large gap remains in available data to produce reliable and clinically meaningful quality measurements across the entire patient pathway.
Candice Donnelly +7 more
wiley +1 more source
Comportamiento de los pólipos de colon y recto en pacientes sometidos a colonoscopia terapéutica
Background: the large intestine extends from the cecum to the orifice of the anus. The mucosa contains in its thickness, numerous tubular glands, in it you can find lesions, polyps are the most frequent. Objective: to determine the behavior of colon and
Natalí García-Morell +4 more
doaj
Summary: Background: Squamous cell carcinoma of the anus (SCCA) annual incidence among sexual minority men with and without HIV is 85/100,000 and 19/100,000 persons, respectively, which is significantly higher than the overall incidence (2/100,000 ...
Alan G. Nyitray +13 more
doaj +1 more source
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski +7 more
wiley +1 more source
The prognostic value of cell-free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus. [PDF]
What's new? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Jakobsen AV +4 more
europepmc +2 more sources
Biopsy‐proven residual tumor at the end of chemoradiation identifies patients at high risk for disease progression. Despite achieving a delayed histologic complete response 6 weeks later, these patients show significantly worse progression‐free survival, suggesting the prognostic value of early tissue‐based response assessment during brachytherapy ...
Christoph Ebner +12 more
wiley +1 more source
Squamous anal cell carcinoma frequency has been changing during the last decades. It was a rare disease in the past with 0.2 cases per 100,000 inhabitants in Denmark before the 60’s and 0.5 per 100,000 in the United States of America (USA) in 1973 ...
José Ricardo Hildebrandt Coutinho
doaj +1 more source
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy +13 more
wiley +1 more source

